ArticleCell death & disease2011

Treatment with a BH3 mimetic overcomes the resistance of latency III EBV (+) cells to p53-mediated apoptosis.

A Pujals et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.